Review and Update of Platelet Alloantigen Systems

Transfusion Medicine Reviews

Volumn 4, Issue 2, 1990, Pages 98-109

  Mueller Eckhardt, C ^a   Kiefel, V ^a   Santoso, S ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN; HLA ANTIGEN; THROMBOCYTE ANTIGEN;

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CLASSIFICATION; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; MIDDLE AGED; NEWBORN; PREGNANCY; PURPURA; REVIEW; THROMBOCYTE; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; BLOOD COMPONENT TRANSFUSION; BLOOD GROUP ANTIGENS; BLOOD PLATELETS; BLOOD TRANSFUSION; FEMALE; HLA ANTIGENS; HUMANS; IMMUNIZATION; INFANT, NEWBORN; ISOANTIBODIES; MALE; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; PREGNANCY; PURPURA; THROMBOCYTOPENIA;

EID: 0025405664     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(90)70254-4     Document Type: Article

References (86)

1. Serological and genetical studies on a platelet antigen (Zw)
2. Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in “autoimmunity”
3. Immunology of platelet disorders
4. Iso-Antigenic Systems of Human Blood Platelets - A survey
5. Evidence of platelet complement-fixing and lymphocytotoxic anti-Al antibodies
6. Lymphocytotoxic sera associated with the ABO and Lewis red cell blood groups
7. Genetics of ABO, H, Lewis, X and related antigens
8. a blood group antigen on human platelets
9. a by platelet complement fixation
10. The amount of blood group A substance on platelets is proportional to the amount in the plasma
11. The origin of ABH antigens on human platelets
12. x) antigens on platelets and lymphocytes
13. Heterogeneous distribution of antigens on human platelets demonstrated by fluorescence flow cytometry
14. Transplantation antigens studied by complement-fixation methods
15. Expression of HLA-B12 on platelets, on lymphocytes and in serum: A quantitative study
16. Further studies of the expression of Bw4, Bw6 and other antigens of the HLA-B locus on human platelets
17. Expression of HLA-B12, HLA-B8, w4, and w6 on platelets
18. Clinical significance of platelet-specific antigens and antibodies
19. Variation of class I HLA antigen expression among platelet density cohorts: A possible index of platelet age?
20. HLA-antigens on circulating platelets
21. HLA-C antigens on platelets
22. Ability of thrombocytes to acquire HLA specificity from plasma
23. Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal anti-body
24. Association between HLA phenotype and HLA concentration in plasma or platelets
25. HLA antigens on platelet membranes: In vitro and in vivo studies
26. Cytoadhesins, integrins, and platelets
27. Adhesive protein receptors on hematopoietic cells
28. b are expressed on the very late activation antigen 2 (VLA-2) of T-lymphocytes
29. The Zw blood group system in platelets
30. Platelet and leucocyte isoantigens and their antibodies: Serologic, physiologic and clinical studies
31. Groupage et détection d’anticorps dans le système PIA (plaquettaire). Application a l’etude des thrombopénies neonatales par allo-immunisation foeto-maternelle PIA1
32. a)
33. Platelet antigens
34. Frequency of P1(A1) in blacks
35. A new platelet antigen system, Yuk(a)/Yuk(b)
36. Yuk(a), a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia
37. New platelet antigen, Sib(a), involved in platelet transfusion refractoriness in a Japanese man
38. Frequency of platelet-specific antigens P1(A1), Bak(a), Yuk(a), Yuk(b), and Br(a) in South American (Mapuches) Indians
39. Isolation and immunologic characterization of the human platelet isoantigen P1(A1)
40. Characterization of platelet-specific alloantigens by immunoblotting: Localization of Zw and Bak antigens
41. Chromosomal localization of the genes for the alpha-subunits of the vitronectin and fibronectin receptors and for the platelet membrane glycoproteins IIb and IIIa
42. Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17
43. Allo-antigens and allo-antibodies of the Ko system, serological and genetic study
44. Neonatal alloimmune amega-karyocytosis
45. Bak(a), a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia
46. Lek(a), a new platelet antigen absent in Glanzmann's thrombasthenia
47. Identification of Bak(b), a new platelet-specific antigen associated with post-transfusion purpura
48. b
49. Immunochemical characterization of platelet-specific alloantigens
50. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a “new” maternal antiplatelet antibody
51. A new platelet-specific alloantigen Br(a). Report of four cases with neonatal alloimmune thrombocytopenia
52. A new platelet-specific alloantigen system, Yuk(a)/Yuk(b) is located on platelet membrane glycoprotein Ilia
53. On the association of the platelet-specific alloantigen, Pen(a), with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa
54. Identification of the Yuk(b) allo-antigen on platelet glycoprotein IIIa
55. The Br(a)/Br(b) alloantigen system on platelets
56. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies
57. Immunochemical characterization of the new platelet alloantigen system Br(a)/Br(b)
58. Human anti-PI(E1) antibody recognizes epitopes associated with the alpha subunit of platelet glycoprotein Ib
59. A new platelet-specific antigen Nak(a) involved in the refractoriness of HLA-matched platelet transfusion
60. Iso-immunisation maternelle anti-plaquettaire et purpura néonatal le système de groupe plaquet taire Duzo
61. Thrombopénies neo-natales allo-immunes. Etude clinique et biologique de 84 cas
62. 348 cases of suspected neonatal alloimmune thrombocytopenia
63. Neonatal alloimmune thrombocytopenia: Detection and characterization of the responsible antibodies by the platelet immunofluorescence test
64. Post-transfusion purpura
65. Posttransfusion purpura
66. Clinical significance of platelet-specific antigens
67. Immunological aspects of platelet transfusions
68. Prevention of alloimmunization in platelet transfusion recipients
69. Serological studies in patients on platelet- and granulocyte-substitution therapy
70. The serology of febrile transfusion reactions
71. Neonatal alloimmune thrombocytopenia due to fetomaternal Zw(b) incompatibility
72. b antibody associated with neonatal alloimmune throm bocytopenia
73. Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen Bak(a)
74. Post-transfusion purpura associated with anti-Bak(a) and anti-Pl(A2) platelet antibodies and delayed haemolytic transfusion reaction
75. Post-transfusion purpura (PTP) due to anti-Zw(b)(–PI(A2): The significance of IgG3 antibodies in PTP
76. Post-transfusion purpura following open heart surgery: Management by high dose intravenous immunoglobulin infusion
77. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions
78. Platelet transfusion therapy
79. Platelet transfusion refractoriness associated with two rare platelet-specific alloantibodies (anti-Bak(a) and anti-PI(A2)) and multiple HLA antibodies
80. An immune response gene linked to MHC in man
81. Allo-immune thrombocytopenias, definition of a group at risk, a prospective study
82. HLA-DRw6, a new immune response marker for immunization against the platelet alloantigen Br(a)
83. Alloimmunization against the platelet specific Zw(a) antigen, resulting in neonatal alloimmune thrombocytopenia or posttransfusion purpura, is associated with the supertypic DRw52 antigen including DR3 and DRw6
84. Immunogenicity of and immune response to the human platelet antigen Zw(a) is strongly associated with HLA-B8 and DR3
85. Is HLA-DR3 a risk factor in PIAI-negative pregnant women?